Gene therapy with Adv-IL-2 in unresectable digestive cancer: phase I-II study, intermediate report

Hepatogastroenterology. 1999 May:46 Suppl 1:1268-73.
No abstract available

Publication types

  • Clinical Trial
  • Clinical Trial, Phase I
  • Clinical Trial, Phase II

MeSH terms

  • Adenocarcinoma / blood
  • Adenocarcinoma / therapy*
  • Adenoviridae* / genetics
  • Adenoviridae* / immunology
  • Adenoviridae* / isolation & purification
  • Adult
  • Antibodies, Viral / blood
  • Antigens, CD / blood
  • Colonic Neoplasms / blood
  • Colonic Neoplasms / therapy
  • Digestive System Neoplasms / blood
  • Digestive System Neoplasms / therapy*
  • Female
  • Genetic Therapy*
  • Genetic Vectors / therapeutic use
  • Humans
  • Injections, Intralesional
  • Interleukin-2 / blood
  • Interleukin-2 / genetics
  • Interleukin-2 / therapeutic use*
  • Interleukins / blood
  • Male
  • Middle Aged
  • Pancreatic Neoplasms / blood
  • Pancreatic Neoplasms / therapy
  • Tumor Necrosis Factor-alpha / metabolism

Substances

  • Antibodies, Viral
  • Antigens, CD
  • Interleukin-2
  • Interleukins
  • Tumor Necrosis Factor-alpha